The Ministry of Health and Welfare on Wednesday announced the availability of programs meant to help people quit smoking, as ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

exploring the biological mechanisms behind these benefits, and assessing the long-term impact of these medications on COPD progression,” he added. MNT had the opportunity to speak with Fady ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

Pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer. Learn more.

Although macrophages, a type of immune cell, had previously been known to contribute to inflammation and scarring in ...

Idiopathic pulmonary fibrosis (IPF) and diabetes mellitus do not appear to have a causal association, according to study findings published in Thorax.

Northwestern Medicine investigators have discovered new mechanisms underlying cellular adhesion and ... Gottardi, Ph.D., ...

Q4 2024 Earnings Call Transcript February 27, 2025 Verona Pharma plc misses on earnings expectations. Reported EPS is $-0.4 ...